CYC.AX ASX
Cyclopharm Limited
1W: -2.2%
1M: -13.7%
3M: -4.3%
YTD: -52.7%
1Y: -53.9%
3Y: -83.4%
5Y: -82.8%
A$0.44 ($0.31)
+0.00 (+0.00%)
Weekly Expected Move ±9.6%
A$0
A$0
A$0
A$0
A$1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$17M
-37.8% ▼
Capital Expenditures
$2M
-105.0% ▼
5Y CAGR: +30.3%
Free Cash Flow
-$19M
-42.6% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$14M
-257.7% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$5M | -$7M | -$5M | -$13M | -$17M |
| Depreciation & Amort. | $759K | $931K | $939K | $1M | $2M |
| Stock-Based Comp. | $757K | $648K | $0 | $0 | $0 |
| Change in Working Capital | $2M | -$2M | -$2M | -$3M | -$3M |
| Other Non-Cash Items | -$9K | $4M | -$978K | $2M | $972K |
| Operating Cash Flow | -$2M | -$7M | -$7M | -$13M | -$17M |
| — Investing Activities — | |||||
| Capital Expenditures | -$1M | -$2M | -$237K | -$804K | -$2M |
| Acquisitions (Net) | $0 | $0 | $30K | $0 | $5M |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | -$301K | -$168K | $0 |
| Investing Cash Flow | -$1M | -$2M | -$508K | -$972K | $3M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$289K | -$289K | -$276K | -$642K | $0 |
| Stock Repurchased | $0 | $0 | $0 | -$1M | $0 |
| Dividends Paid | -$881K | -$883K | -$885K | $0 | $0 |
| Other Financing | $0 | $446K | $142K | $6K | -$1M |
| Financing Cash Flow | $30M | -$726K | -$1M | $22M | -$1M |
| Net Change in Cash | $27M | -$9M | -$9M | $9M | -$14M |
| Cash End of Period | $29M | $20M | $12M | $21M | $7M |
| Free Cash Flow | -$3M | -$8M | -$8M | -$14M | -$19M |